A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia

Số trang: 13 Loại file: pdf Dung lượng: 1.48 MB Lượt xem: 23 Lượt tải: 0

Thư Viện Số

Báo xấu

Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

The real-world experience of Swiss chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) is largely unknown, in particular with regard to achievement of response per European Leukemia Net (ELN) criteria and adherence to ELN recommendations.

Tìm kiếm theo từ khóa liên quan:

BMC Cancer Chronic myeloid leukemia Deep molecular response Real-world evidence Tyrosine kinase inhibitors

Tài liệu có liên quan:

Differences between physician and patient preferences for cancer treatments: A systematic review

13 trang 179 0 0
Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer

6 trang 171 0 0
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation

7 trang 150 0 0
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France

9 trang 135 0 0
Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment – oxaliplatin subscale: A prospective cohort study

12 trang 103 0 0
LAP3 contributes to IFN-γ-induced arginine depletion and malignant transformation of bovine mammary epithelial cells

19 trang 81 0 0
Eribulin normalizes pancreatic cancer-associated fibroblasts by simulating selected features of TGFβ inhibition

17 trang 71 0 0
Determinants of late-stage cervical cancer presentation in Ethiopia: A systematic review and meta-analysis

9 trang 48 0 0
Expression of deubiquitinase genes and inflammatory response in Myeloid leukemia

8 trang 45 0 0
Appropriate dose of regorafenib based on body weight of colorectal cancer patients: A retrospective cohort study

9 trang 43 0 0